fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
Published 7 years ago • 240 plays • Length 9:27
Download video MP4
Download video MP3
Similar videos
-
10:18
fda approvals in bladder cancer and hodgkin lymphoma, breakthrough designation in aml, and more
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
9:11
fda approval in tgct, breakthrough designation in melanoma, and more
-
6:59
fda approval in nsclc, priority review in bladder cancer, mbcc highlights, and more
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
2:03
durvalumab fda approval for bladder cancer
-
13:01
fda approvals in urothelial cancer and prostate cancer, priority review in crc, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
6:13
fda approval in carcinoid syndrome diarrhea, priority reviews in bladder cancer and nsclc, and more
-
8:43
fda approvals in bladder cancer and nsclc, and 2019 elcc highlights
-
1:49
fda approval of durvalumab for bladder cancer
-
8:05
fda approvals in nsclc, bladder cancer, and breast cancer, and death in car t-cell therapy trial
-
18:36
breakthrough in bladder cancer: fda approval - enfortumab vedotin pelbrolizumab with dr.tom powles
-
5:14
clinical hold on pacritnib, breakthrough designation in sarcoma, and more
-
6:58
fda approvals in nsclc and soft tissue sarcoma, priority review in bladder cancer, and more
-
7:05
the fda approval of atezolizumab in bladder cancer
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer
-
9:07
fda approvals in breast cancer and bladder cancer and phase iii data with larotrectinib
Clip.africa.com - Privacy-policy